Pricing Log in Create free account
Saturday 17 October 2026 Export TMO’s income statement to Excel — free account

Thermo Fisher Scientific Inc.

TMO Healthcare Diagnostics & Research

Thermo Fisher Scientific Inc.’s revenue for fiscal 2025 (year ended December 2025) was $44.6 billion, up 3.91% from fiscal 2024. In the quarter to June 2026, revenue grew 10.5%, EPS grew 9.35%, free cash flow grew 51.8% and total debt rose 18.7%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.

690.00 6.49 −0.93%
Market cap
$257.5B
P/E
37.1×
Fwd P/E
23.7×
Dividend yield
0.27%
F-score
5/9
Altman Z
3.84
Beneish M
−2.46
Dividend safety
88/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Thermo Fisher Scientific Inc. (TMO) EPS (diluted)

Alert me on EPS (diluted)

Thermo Fisher Scientific Inc.'s EPS (diluted) for fiscal 2025 was $17.74, up 7.32% from $16.53 in fiscal 2024. Over the twelve months to 30 June 2026 it was $18.59. Over the past ten years it has ranged from $4.92 (fiscal 2015) to $19.46 (fiscal 2021); the current reading is higher than 91% of that period. Thermo Fisher Scientific Inc. ranks 3rd of 52 Diagnostics & Research companies by EPS (diluted).

EPS (diluted), annual

Embed this chart

Annual newest first

Period EPS (diluted) Change
FY2025 $17.74 7.32%
FY2024 $16.53 6.99%
FY2023 $15.45 (12.37%)
FY2022 $17.63 (9.40%)
FY2021 $19.46 21.93%
FY2020 $15.96 74.05%
FY2019 $9.17 26.66%
FY2018 $7.24 29.52%
FY2017 $5.59 9.82%
FY2016 $5.09 3.46%

Quarterly newest first

Period EPS (diluted) Change
Jun 2026 $4.68 5.64%
Mar 2026 $4.43 (14.97%)
Dec 2025 $5.21 22.01%
Sep 2025 $4.27 (0.23%)
42 more quarters

Against its own ten years

Low $4.92 High $19.46
Ten-year median $15.45
Current reading's percentile 91

EPS (diluted) against peers

Company EPS (diluted)
MTD Mettler-Toledo International, Inc. compare $44.43
TMO Thermo Fisher Scientific Inc. $18.59
IDXX IDEXX Laboratories, Inc. compare $14.22
IQV IQVIA Holdings Inc. compare $8.06
DHR Danaher Corporation compare $5.63
ILMN Illumina, Inc. compare $5.36
A Agilent Technologies, Inc. compare $5.08
WAT Waters Corporation compare $4.01
NTRA Natera, Inc. compare −$1.36

What EPS (diluted) is

Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.

Reported line item

The full definition of EPS (diluted) →

More on TMO